Saturday 17 October 2026
Export HDSN’s income statement to Excel — free account
Hudson Technologies, Inc.
HDSN Basic Materials Specialty Chemicals
Hudson Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $246.6 million, up 4.00% from fiscal 2024. In the quarter to June 2026, revenue grew 7.54%, EPS fell 47.8% and free cash flow grew 5.45%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.01
0.03
−0.60%
Follow HDSN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
19.47 | 18.51 | 18.50 | 27.62 |
P/S ratio |
1.83 | 1.21 | 0.99 | 0.94 | |
P/FCF ratio |
9.72 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
49.19 | (9.17) | (19.43) | 35.26 | |
P/B ratio |
1.63 | 1.23 | 1.05 | 0.99 | |
Price to Tangible BV |
2.26 | 1.79 | 1.54 | 1.43 | |
EV/Sales |
1.58 | 1.17 | 1.03 | 0.96 | |
EV/EBITDA |
11.31 | 11.67 | 11.13 | 13.54 | |
EV/Operating CF |
7.46 | (91.46) | (8.62) | (8.29) | |
EV/FCF |
8.39 | (35.11) | (7.45) | (7.12) | |
Quick Ratio |
1.86 | 0.97 | 0.97 | 1.12 | |
Current Ratio |
3.66 | 3.26 | 3.38 | 3.23 | |
Net Debt/EBITDA |
(5.80) | 4.05 | (5.94) | (2.79) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.73 | 0.79 | 0.82 | 0.80 | |
Operating CF/Net income |
0.71 | 3.77 | (38.80) | 1.38 | |
Capex/Depreciation |
(1.39) | (0.75) | (0.60) | (0.32) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.00% | 31.35% | 15.84% | 15.87% | |
Intangible Assets out of Total Assets |
0.22 | 0.24 | 0.25 | 0.23 | |
Share Based Compensation of Revenue |
0.13% | 1.06% | 0.28% | 0.86% | |
Graham Net Nets |
0.37 | 0.45 | 0.53 | 0.58 | |
Graham Number |
8.36 | 6.82 | 6.34 | 5.20 | |
Earnings Yield |
5.14% | 5.40% | 5.40% | 3.62% | |
Free Cash Flow Yield |
10.28% | (2.76%) | (14.01%) | (14.30%) | |
Revenue per Share |
1.70 | 1.02 | 1.42 | 1.86 | |
Operating CF per Share |
0.20 | (0.75) | (0.30) | 0.16 | |
Capex per Share |
(0.05) | (0.03) | (0.03) | (0.01) | |
Free Cash Flow per Share |
0.15 | (0.77) | (0.33) | 0.15 | |
Cash per Share |
2.05 | 0.91 | 0.46 | 0.61 | |
Shareholders Equity per Share |
6.09 | 5.58 | 5.62 | 5.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.09 | 5.58 | 5.62 | 5.78 | |
Free Cash Flow |
6.75 | (33.65) | (13.88) | 6.27 | |
Working Capital |
170.33 | 146.24 | 142.96 | 150.65 | |
Capital Expenditures |
(2.07) | (1.11) | (1.07) | (0.58) | |
Net Current Asset Value |
161.30 | 135.58 | 131.84 | 139.35 | |
EV/EBIT |
14.10 | 15.58 | 15.32 | 21.16 | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.01 | |
Price to Operating Income |
16.34 | 16.09 | 14.68 | 20.78 | |
| Other line items | |||||
Average Receivables |
30.92 | 21.46 | 36.17 | 44.60 | |
Average Payables |
15.53 | 14.90 | 14.43 | 17.79 | |
Average Inventory |
100.47 | 116.09 | 104.52 | 102.90 | |
Average Assets |
324.19 | 310.65 | 308.40 | 319.96 | |
Average Common Equity |
259.89 | 244.62 | 242.25 | 249.02 |
Columns are period end dates